The Association Between Low Serum Cholesterol and Non-Cardiovascular Mortality among Italian Males and Females: A Nine- Year Prospective Cohort Ctudy


Journal

Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625

Informations de publication

Date de publication:
25 May 2019
Historique:
entrez: 26 5 2019
pubmed: 28 5 2019
medline: 18 12 2019
Statut: epublish

Résumé

Background: No study to date provides evidence suggesting that lower cholesterol is associated with excess death in non-cardiovascular disease (NCVD). This study aimed to determine the association between low cholesterol level and NCVD mortality. Methods: A nine-year cohort study was conducted on 3,079 male and 26,005 female Italians aged 20-69 years old. The Cox proportional hazard models implied a hazard ratio with 95% confidence interval for association. Results: Among males, there were significant inverse associations between the lowest cholesterol decile (< 160mg/dl) hazard ratio and all-cause deaths and non-cardiovascular deaths, 1.50 (1.19-1.89) and 2.06 (1.54-2.74), respectively. Among females, there was a significant inverse association of lowest and fourth cholesterol deciles, 1.53 (1.01-2.34); 1.52 (1.06-2.18) hazard ratio for all-cause deaths and risk for non-cardiovascular deaths in the same deciles 1.52 (0.91-2.50); 1.78 (1.16-2.71), respectively. Remarkably, in depth analysis for NCVD, found significant inverse associations hazard of cholesterol <160 mg/dl for cancer, non-cancer liver dysfunction (NCLD), other non-cancer-non- CVD in males and only NCLD death was significant in females. Conclusion: Among males, there were significant inverse hazard associations between the lowest cholesterol decile and all-cause and non-CVD deaths . Among females, there were significant inverse hazard associations of lowest and fourth cholesterol decile for all-cause and also risk first and fourth deciles for non-CVD mortality.

Identifiants

pubmed: 31127892
doi: 10.31557/APJCP.2019.20.5.1361
pmc: PMC6857883

Substances chimiques

Cholesterol 97C5T2UQ7J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1361-1368

Informations de copyright

Creative Commons Attribution License

Références

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1784-1793
pubmed: 27515591
J Clin Epidemiol. 1992 Apr;45(4):333-46
pubmed: 1569429
Am J Epidemiol. 1980 Sep;112(3):388-94
pubmed: 7424886
Circulation. 1990 Dec;82(6):1916-24
pubmed: 2242517
Lancet. 1986 Oct 25;2(8513):933-6
pubmed: 2877128
J Clin Lipidol. 2013 May-Jun;7(3):208-16
pubmed: 23725920
Lancet. 1987 Aug 8;2(8554):298-301
pubmed: 2886765
JAMA. 1992 Jan 1;267(1):70-6
pubmed: 1727199
J Gerontol. 1991 May;46(3):M84-90
pubmed: 2030271
Am J Epidemiol. 1981 Jul;114(1):29-40
pubmed: 7246528
J Biol Chem. 1989 Jun 15;264(17):10264-70
pubmed: 2722868
J Affect Disord. 2014 Jan;152-154:517-21
pubmed: 24007784
Arch Intern Med. 1992 Jul;152(7):1490-500
pubmed: 1627030
Eur J Cancer Prev. 2018 Nov;27(6):570-576
pubmed: 28683011
Circulation. 1992 Sep;86(3):1046-60
pubmed: 1355411
Am J Med. 1986 May;80(5):871-8
pubmed: 3706375
Biochim Biophys Acta. 2013 Apr;1835(2):219-29
pubmed: 23357067
N Engl J Med. 1989 Apr 6;320(14):904-10
pubmed: 2619783
J Natl Cancer Inst. 1989 Dec 20;81(24):1917-21
pubmed: 2593170
J Lipid Res. 1990 Jun;31(6):1099-107
pubmed: 2373960
Keio J Med. 2012;61(3):79-88
pubmed: 23018490
Sex Health. 2017 Oct;14(5):423-430
pubmed: 29216968

Auteurs

Samira Taravatmanesh (S)

Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Email: drnaderparsabe930@gmail.com

Nader Parsa (N)

Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Email: drnaderparsabe930@gmail.com

Maurizio Trevisan (M)

City College of New York (“CCNY”), Provost and Senior Vice President for Academic Affairs, Dean of Medical School, New York, United States.

Pari Mahleaghae Zaheri (PM)

Shiraz University of Medical Sciences, Shiraz, Iran

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH